Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry

Koc Marcin, Kostrubiec Maciej, Elikowski Waldemar, Meneveau Nicolas, Lankeit Mareike, Grifoni Stefano, Kuch-Wocial Agnieszka, Petris Antoniu, Zaborska Beata, Stefanovic Branislav S., Hugues Thomas, Torbicki Adam, Konstantinides Stavros, Pruszczyk Piotr

Source: Eur Respir J 2016; 47: 869-875
Journal Issue: March
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Koc Marcin, Kostrubiec Maciej, Elikowski Waldemar, Meneveau Nicolas, Lankeit Mareike, Grifoni Stefano, Kuch-Wocial Agnieszka, Petris Antoniu, Zaborska Beata, Stefanovic Branislav S., Hugues Thomas, Torbicki Adam, Konstantinides Stavros, Pruszczyk Piotr. Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry. Eur Respir J 2016; 47: 869-875

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
ERJ March Podcast: report from the Right Heart Thrombi European Registry
Source: Eur Respir J 2016; 47: E63
Year: 2016

Insights on right ventricular dysfunction in World Symposium of Pulmonary Hypertension Group 3 PH
Source: Virtual Congress 2020 – Right ventricular function and pulmonary hypertension
Year: 2020




Systemic Coronary Risk Evaluation and pulmonary hypertension, right and left ventricular dysfunction in patients with COPD
Source: Annual Congress 2010 - COPD: cardiovascular comorbidities
Year: 2010


Evaluation of Pulmonary Complication in Patient with Valvular Heart Surgery: Clinical and Laboratory Significances
Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems
Year: 2018

Distribution of body water in hospitalized patients with Chronic Obstructive Pulmonary Disease and Right Heart Failure.
Source: International Congress 2019 – Cardiovascular comorbidities in COPD
Year: 2019


Prognostic value of TDI assessment of right ventricular function in patients with acute pulmonary embolism
Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology
Year: 2014


The phenotype of the Adult Mexican Patient with Pulmonary Arterial Hypertension: Baseline characteristics of the REMEHIP Registry. The REMEHIP Investigators.
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018


Myocardial metabolic changes in experimental non-hypertrophied and hypertrophied right ventricular failure
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014

Late Breaking Abstract - Validation of the REVEAL 2.0 Risk Score with the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019



Study Of Risk Factors For Arrhythmias Among Chronic Obstructive Pulmonary Disease Patients Having Ischaemic Heart Disease.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019


Left atrial enlargement is not rare in PAH- RA/LA ratio is significantly lower in PH due to left heart disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

Association Between the Distribution of Body Fluid and Mortality in Heart Failure patients.
Source: International Congress 2017 – The acute patient: the clinical point-of-view
Year: 2017


Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP)
Source: International Congress 2018 – Pulmonary hypertension: therapy
Year: 2018

The Latin American Idiopathic Pulmonary Fibrosis Registry (REFIPI): Baseline Characteristics
Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia
Year: 2019


Ambulatory treatment of low-risk pulmonary embolism in fragile patients: a subgroup analysis of the multinational Home Treatment of Pulmonary Embolism (HoT-PE) Trial
Source: Eur Respir J, 56 (4) 2000663; 10.1183/13993003.00663-2020
Year: 2020



Increased Risk of Heart Failure In Patients of Bronchiectasis – A Nationwide Population-Based Study
Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry
Year: 2019

Cardiac Cormorbidities in COPD Patients : A Cross Sectional Study
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021

Treatment of patients with idiopathic pulmonary fibrosis in real-life setting: Results from the Latin American Pulmonary Fibrosis Registry REFIPI
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019


Measurement of cardiac troponin identifies patients with moderate to large pulmonary emboli and right ventricular strain
Source: International Congress 2014 – Acute pulmonary embolism
Year: 2014

Prognostic significance of right heart thrombi (RHT) in patients with acute symptomatic pulmonary embolism: Systematic review and meta-analysis
Source: International Congress 2016 – Pulmonary hypertension and chronic thromboembolic pulmonary hypertension
Year: 2016